COA Available
Performance In Stock Research Use Only
CJC-1295 (with DAC)
5mg · Lyophilized Powder · Purity ≥99%
CJC-1295 with DAC is a modified GHRH analogue that incorporates a Drug Affinity Complex — a lysine residue functionalised with a maleimido-propionic acid linker — enabling covalent binding to circulating albumin and extending half-life to approximately 6–8 days in animal models. It is studied in research examining prolonged GHRH receptor engagement and long-duration pituitary signalling models.
$69.99 CAD
Purchase Options
Subscriptions can be managed from your customer account. Prices in CAD.
Research Overview
The DAC modification exploits the abundance and long circulatory half-life of serum albumin to create a depot-like pharmacokinetic profile for the GHRH peptide backbone. In preclinical models, this results in sustained GH axis stimulation over multi-day periods, providing a tool for studying the downstream consequences of prolonged GHRH receptor engagement on GH secretion patterns and somatotroph biology. BME Health supplies CJC-1295 with DAC at ≥98% purity by HPLC with full COA documentation. Supplied exclusively for laboratory and research use.
Research utilising CJC-1295 with DAC has focused on prolonged GHRH receptor pharmacology, albumin-drug conjugation strategies, and the downstream GH and IGF-1 axis responses to sustained pituitary stimulation in animal models. Comparative studies with the non-DAC variant have been used to investigate the biological consequences of pulsatile versus continuous GHRH receptor activation on somatotroph function. The compound also serves as a model system for albumin-binding drug delivery research. All outcomes referenced pertain to preclinical models and do not constitute evidence of clinical efficacy or safety in humans.
Specifications
| Compound | CJC-1295 (with DAC) |
| Format | Lyophilized Powder |
| Size | 5mg |
| Purity (HPLC) | ≥99% |
| Item # | BME-CJC129-A |
| Storage | −20°C, dry, dark |
| Price (CAD) | $69.99 |
COA / Testing
Batch documentation and third-party testing information are available for batch BME-CJC129-A. COA previews appear only when documentation exists for the active batch.
Storage & Handling
Store lyophilised CJC-1295 with DAC at −20°C in its original sealed vial, protected from light and moisture. Avoid repeated freeze-thaw cycles, which may disrupt the maleimide linker chemistry and compromise the DAC functional group. Reconstituted solutions should be aliquoted and stored at −80°C; refer to lot-specific COA documentation for stability parameters.
Shipping & Returns
Orders are processed on business days. Packaging is selected to maintain compound integrity in transit. Shipping timelines and return conditions are outlined in full in the Shipping & Returns policy — review before checkout if you have specific requirements. For orders with time-sensitive research schedules, contact support before placing your order.
Research Use Disclaimer
This product is supplied strictly for in-vitro and laboratory research use. It is not a drug, food supplement, or cosmetic and is not approved for human or veterinary clinical applications, diagnostics, or therapeutic use. Researchers are responsible for compliance with all applicable institutional and regulatory requirements in their jurisdiction.
Preparation Reference Guide
Research Solution Reference Calculator
Pre-filled with 5mg. Enter your solvent volume and target amount to see concentration and units on a U-100 syringe scale.
Concentration—
Volume to draw—
Syringe units (U-100)—
Per insulin unit—
For research-use calculations only. Always verify measurements independently — not medical guidance.
Questions before you order?
Browse the FAQ for documentation, storage, and sourcing answers, or contact our support team directly. We aim to respond to all research procurement inquiries within one business day.
Related
